Fairchild Brothers & Foster

Fairchild Brothers & Foster was a drug manufacturer which was based in New York City in the 1930s. Thomas Fairchild (1851–1939), of Quaker Ridge, New Rochelle, New York, was one of the firm's founders, and its president. He was born in Stratford, Connecticut.

Formation of company

Fairchild studied at Stratford Academy and graduated from Philadelphia College of Pharmacy. Afterward he joined Caswell Havard & Company of New York. Later he organized Fairchild Brothers & Foster together with his brother Samuel W. Fairchild and Macomb G. Foster.[1]

Acquisition by rival company

The company was acquired by Sterling Drug, Inc., in February 1946. Fairchild Brothers & Foster specialized in making drugs to assist digestive disorders. Among the drugs it produced were Marinol, Phisoderm, and Enzymo.

Stearns & Company, a subsidiary of Sterling Drug, Inc., took over the distribution of all except three drugs made by the acquired concern. Winthrop Chemical Company, also a Sterling subsidiary, resumed the manufacture of Marinol, Phisoderm, and Enzymo.[2]

References

  1. ↑ B.T. Fairchild Dies Of Fractured Skull, New York Times, March 26, 1939, pg. 58.
  2. ↑ Sterling Brothers Inc., Acquires Fairchild Brothers & Foster, Wall Street Journal, February 13, 1946, pg. 12.
This article is issued from Wikipedia - version of the Monday, October 19, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.